tiprankstipranks
AstraZeneca’s MATTERHORN Phase III trial showed improvement in endpoint of EFS
PremiumThe FlyAstraZeneca’s MATTERHORN Phase III trial showed improvement in endpoint of EFS
5d ago
AstraZeneca Awards Shares to CEO and CFO Under Incentive Plans
Premium
Company Announcements
AstraZeneca Awards Shares to CEO and CFO Under Incentive Plans
7d ago
AstraZeneca Announces Share Capital and Voting Rights Update
Premium
Company Announcements
AstraZeneca Announces Share Capital and Voting Rights Update
9d ago
Amgen, AstraZeneca announce results from Phase 3 WAYPOINT trial on tezspire
PremiumThe FlyAmgen, AstraZeneca announce results from Phase 3 WAYPOINT trial on tezspire
10d ago
AIM announces principal investigator for Ampligen, FluMist clinical study
Premium
The Fly
AIM announces principal investigator for Ampligen, FluMist clinical study
12d ago
AstraZeneca Enhertu recommended for approval in EU by CHMP
Premium
The Fly
AstraZeneca Enhertu recommended for approval in EU by CHMP
12d ago
AstraZeneca announces results from interim analysis of SERENA-6 Phase III trial
PremiumThe FlyAstraZeneca announces results from interim analysis of SERENA-6 Phase III trial
14d ago
AstraZeneca’s Promising Pipeline and Positive Trial Results Justify Buy Rating
Premium
Ratings
AstraZeneca’s Promising Pipeline and Positive Trial Results Justify Buy Rating
14d ago
AstraZeneca’s Camizestrant Shows Promising Results in Advanced Breast Cancer Trial
Premium
Company Announcements
AstraZeneca’s Camizestrant Shows Promising Results in Advanced Breast Cancer Trial
15d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100